Acute Fatty Liver of Pregnancy: A Life-Threatening Condition Requiring a Life-Saving Approach

authors:

avatar Mansoureh Gorginzadeh 1 , avatar Saeid Safari 2 , avatar Seyed Moayed Alavian ORCID 3 , 4 , *

Department of Obstetrics and Gynecology, Tehran University of Medical Sciences, Tehran, IR Iran
Department of Anesthesiology and Critical Care, Iran University of Medical Sciences, Tehran, IR Iran
Baqiyatallah Research Center for Gastroenterology and Liver Diseases, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
Tehran Hepatitis Center, Tehran, IR Iran

how to cite: Gorginzadeh M, Safari S, Alavian S M. Acute Fatty Liver of Pregnancy: A Life-Threatening Condition Requiring a Life-Saving Approach. Hepat Mon. 2016;16(6):e35256. https://doi.org/10.5812/hepatmon.35256.

References

  • 1.

    Engelmann G, Hoffmann GF, Grulich-Henn J, Teufel U. Alanine aminotransferase elevation in obese infants and children: a marker of early onset non alcoholic Fatty liver disease. Hepat Mon. 2014;14(4):14112. [PubMed ID: 24748893]. https://doi.org/10.5812/hepatmon.14112.

  • 2.

    Bugianesi E, McCullough AJ, Marchesini G. Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology. 2005;42(5):987-1000. [PubMed ID: 16250043]. https://doi.org/10.1002/hep.20920.

  • 3.

    Xiong HF, Liu JY, Guo LM, Li XW. Acute fatty liver of pregnancy: over six months follow-up study of twenty-five patients. World J Gastroenterol. 2015;21(6):1927-31. [PubMed ID: 25684961]. https://doi.org/10.3748/wjg.v21.i6.1927.

  • 4.

    Vigil-de Gracia P, Montufar-Rueda C. Acute fatty liver of pregnancy: diagnosis, treatment, and outcome based on 35 consecutive cases. J Matern Fetal Neonatal Med. 2011;24(9):1143-6. [PubMed ID: 21668324]. https://doi.org/10.3109/14767058.2010.531325.

  • 5.

    Riely CA. Liver disease in the pregnant patient. Am J Gastroenterol. 1999;94(7):1728-32. [PubMed ID: 10406228]. https://doi.org/10.1111/j.1572-0241.1999.01199.x.

  • 6.

    Shah JM, Mehta MN, Viradiya HB. Acute fatty liver of pregnancy. IJCP. 2013;23(9):550-2.

  • 7.

    Kamimura K, Abe H, Kawai H, Kamimura H, Kobayashi Y, Nomoto M, et al. Advances in understanding and treating liver diseases during pregnancy: A review. World J Gastroenterol. 2015;21(17):5183-90. [PubMed ID: 25954092]. https://doi.org/10.3748/wjg.v21.i17.5183.

  • 8.

    Goel A, Jamwal KD, Ramachandran A, Balasubramanian KA, Eapen CE. Pregnancy-related liver disorders. J Clin Exp Hepatol. 2014;4(2):151-62. [PubMed ID: 25755551]. https://doi.org/10.1016/j.jceh.2013.03.220.

  • 9.

    Kobayashi T, Minami S, Mitani A, Tanizaki Y, Booka M, Okutani T, et al. Acute fatty liver of pregnancy associated with fetal mitochondrial trifunctional protein deficiency. J Obstet Gynaecol Res. 2015;41(5):799-802. [PubMed ID: 25420603]. https://doi.org/10.1111/jog.12609.

  • 10.

    Cowie P, Johnston IG. Acute Fatty Liver of Pregnancy. London: ATOTW; 2010. p. 1-5.

  • 11.

    Ko H, Yoshida EM. Acute fatty liver of pregnancy. Can J Gastroenterol. 2006;20(1):25-30. [PubMed ID: 16432556].

  • 12.

    Zhu T, Li Q, Zhang W, Huang J, Peng Q, Liu Y, et al. Screening time and schedule for outpatients with acute fatty liver of pregnancy. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2015;40(7):748-53. [PubMed ID: 26267687].

  • 13.

    Mohammad Jafari R, Saadati N, Rezaie M. Acute Fatty Liver of Pregnancy: A Clinical-Paraclinical Survey. JJHR. 2015;6(1). https://doi.org/10.5812/jjhr.27808.

  • 14.

    Meng J, Wang S, Gu Y, Lv H, Jiang J, Wang X. Prenatal predictors in postpartum recovery for acute fatty liver of pregnancy: experiences at a tertiary referral center. Arch Gynecol Obstet. 2016;293(6):1185-91. [PubMed ID: 26525698]. https://doi.org/10.1007/s00404-015-3941-5.

  • 15.

    Association of Anaesthetists of Great Britain and Ireland, Thomas D, Wee M, Clyburn P, Walker I, et al. Blood transfusion and the anaesthetist: management of massive haemorrhage. Anaesthesia. 2010;65(11):1153-61. [PubMed ID: 20963925].

  • 16.

    Stainsby D, Jones H, Asher D, Atterbury C, Boncinelli A, Brant L, et al. Serious hazards of transfusion: a decade of hemovigilance in the UK. Transfus Med Rev. 2006;20(4):273-82. [PubMed ID: 17008165]. https://doi.org/10.1016/j.tmrv.2006.05.002.

  • 17.

    Crochemore T, de Toledo Piza FM, Silva E, Correa TD. Thromboelastometry-guided hemostatic therapy: an efficacious approach to manage bleeding risk in acute fatty liver of pregnancy: a case report. J Med Case Rep. 2015;9(1):202. [PubMed ID: 26395443]. https://doi.org/10.1186/s13256-015-0690-9.

  • 18.

    K S, Thunga S, Narayanan A, Singh P. Recombinant activated factor VII in the management of acute fatty liver of pregnancy: A case report. J Obstet Gynaecol Res. 2015;41(7):1122-5. [PubMed ID: 25809227]. https://doi.org/10.1111/jog.12684.

  • 19.

    Ding J, Han LP, Lou XP, Geng LN, Liu D, Yang Q, et al. Effectiveness of combining plasma exchange with plasma perfusion in acute fatty liver of pregnancy: a retrospective analysis. Gynecol Obstet Invest. 2015;79(2):97-100. [PubMed ID: 25634306]. https://doi.org/10.1159/000368752.

  • 20.

    Arya S, Richardson CJ, Jain S, Swischuck LE. Early Vitamin K Deficiency Bleeding in a Neonate Associated with Maternal Acute Fatty Liver of Pregnancy. AJP Rep. 2015;5(2):193-5. [PubMed ID: 26495183]. https://doi.org/10.1055/s-0035-1557107.